GU CONNECT Prostate Cancer Management Masterclass: plenary session recordings (videos and slides)
Assoc. Prof. Alicia Morgans MD, MPH summarises the recent interactive Prostate Cancer Management Masterclass that she co-hosted, along with Dr. Neal Shore, MD, FACS, Assoc. Prof. Tanya Dorff, MD and Prof. Evan Yu, MD.
Watch the on-demand plenary sessions and download the slides.
Assoc. Prof. Alicia Morgans, MD, MPH as a faculty member for the GU CONNECT Prostate Cancer Masterclass, quickly explains what you can learn from the educational materials available to you below.
- Assoc. Prof. Tanya Dorff, MD and Prof. Evan Yu, MD present “Next-generation” sequencing of therapy for Castration-Resistant Prostate Cancer (CRPC)
- Dr. Neal Shore, MD, FACS and Assoc. Prof. Alicia Morgans, MD, MPH present Paradigm shift in the management of metastatic castration-sensitive prostate cancer (mCSPC)
Paradigm shift in the management of metastatic castration-sensitive prostate cancer (mCSPC) by Dr. Neal Shore, MD, FACS and Assoc. Prof. Alicia Morgans, MD, MPH
Hi, my name is Alicia Morgans and I am a GU Medical Oncologist and Associate Professor of Medicine at Northwestern University in Chicago in the United States. I’m delighted to talk with you today about the GU CONNECT Prostate Cancer Masterclass in which I was recently able to participate.
I hosted this masterclass with co-hosts Dr. Tanya Dorff, Dr. Evan Yu and Dr. Neal Shore and together we provided a multidisciplinary approach to the treatment of men with prostate cancer.
Importantly we included perspectives from a radiation oncologist and a nuclear medicine physician as well as a nurse practitioner in our multidisciplinary care approaches and our discussions.
We also were able to engage with an international audience and group of participants who provided questions and really lent their opinions in this very complex treatment paradigm. Some of the focuses that we had during this masterclass were highlighted in two plenary sessions that you can download and review on your own.
Hormone-sensitive metastatic prostate cancer
One was on hormone-sensitive metastatic prostate cancer and considerations for treatment intensification as well as considering treating the local prostate in patients with low volume metastatic disease.
Metastatic castration-resistant prostate cancer
We also spoke about treatment of metastatic castration-resistant prostate cancer and how we really need to focus on changing mechanism of action and really think about how to best sequence all of the therapies that we have available.
Finally we thought about genetic testing, we talked about multidisciplinary care and really tried to highlight how we can work together as a multidisciplinary team to get the best outcomes for our patients.
All of these discussions and the plenary sessions are available online on the GU CONNECT website which you can access by going to guconnect.info where you can find all of these resources.
I’m sure that you’ll find it interesting and entertaining and I also encourage you to look for future GU CONNECT and other CONNECT resources in the future.
Thank you so much for your time and I hope you enjoy the resources
Please respond on a scale of 1 to 5 (5=strongly agree).